Sciegen Pharmaceuticals Inc FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · May 15, 2026
  • No warning letters matched by name
Inspections 14 1 OAI
Recalls 7 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Sciegen Pharmaceuticals Inc has 7 FDA recalls, 14 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Sciegen Pharmaceuticals Inc" is on file.

What these totals cover: FDA records filed under the name "Sciegen Pharmaceuticals Inc" and its spelling variant "Sciegen Pharmaceuticals".

Latest recall
D-0354-2023 · Class III · Feb 17, 2023
Latest inspection
May 15, 2026 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls7Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections14Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Sciegen Pharmaceuticals Inc's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Sciegen Pharmaceuticals Inc: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 3 inspections (0 OAI), 0 warning letters, 6 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 1 inspection (1 OAI), 0 warning letters, 1 recall record (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202610000
202510000
202410000
202311010
202210000
202110000
202000000
201910000
201830060
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Sciegen Pharmaceuticals Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Sciegen Pharmaceuticals Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

7 recall records from Oct 29, 2018 to Feb 17, 2023.

NumberClassProductDate
D-0354-2023Class IIIGabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen…Feb 17, 2023
D-0271-2019Class IIGSMS Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle…Oct 29, 2018
D-0268-2019Class IIWestminister Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 69367-120-01), (b) 90-count…Oct 29, 2018
D-0267-2019Class IIWestminister Irbesartan Tablets, USP, 75 mg (a) 30-count bottle (NDC 69367-119-01), (b) 90-count…Oct 29, 2018
D-0270-2019Class IIGSMS Irbesartan Tablets, USP, 75 mg, 30-count bottle, Rx Only, Manufactured by ScieGen…Oct 29, 2018
D-0272-2019Class IIGSMS Irbesartan Tablets, USP, 300 mg,(a) 30-count bottle (NDC 60429-642-30), (b) 90-count bottle…Oct 29, 2018
D-0269-2019Class IIWestminister Irbesartan Tablets, USP, 300mg, Rx Only,(a) 30-count bottle (NDC 69367-121-01, (b)…Oct 29, 2018

Recent FDA inspections

14 inspections from Sep 16, 2011 to May 15, 2026.

DateSiteProductClassificationFEI
May 15, 2026Hauppauge, NYDrugsVoluntary Action Indicated (VAI)3008298016
Dec 19, 2025Hauppauge, NYDrugsNo Action Indicated (NAI)3008298016
Feb 20, 2024Hauppauge, NYDrugsNo Action Indicated (NAI)3008298016
Apr 21, 2023Hauppauge, NYDrugsOfficial Action Indicated (OAI)3008298016
Sep 2, 2022Hauppauge, NYDrugsVoluntary Action Indicated (VAI)3008298016
Dec 20, 2021Hauppauge, NYDrugsVoluntary Action Indicated (VAI)3008298016
Jun 21, 2019Hauppauge, NYDrugsVoluntary Action Indicated (VAI)3008298016
Apr 20, 2018Hauppauge, NYDrugsNo Action Indicated (NAI)3008298016
Mar 16, 2018Hauppauge, NYDrugsNo Action Indicated (NAI)3008298016
Mar 14, 2018Hauppauge, NYDrugsNo Action Indicated (NAI)3008298016
Jan 9, 2015Hauppauge, NYDrugsVoluntary Action Indicated (VAI)3008298016
Sep 18, 2013Hauppauge, NYDrugsNo Action Indicated (NAI)3008298016
Apr 2, 2013Hauppauge, NYDrugsNo Action Indicated (NAI)3008298016
Sep 16, 2011Hauppauge, NYDrugsVoluntary Action Indicated (VAI)3008298016
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3008298016Hauppauge, NY14May 15, 2026

Sciegen Pharmaceuticals Inc and the FDA: common questions

Has Sciegen Pharmaceuticals Inc received an FDA warning letter?

No FDA warning letter addressed to the name "Sciegen Pharmaceuticals Inc" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Sciegen Pharmaceuticals Inc received an FDA Form 483?

FDA has not published a Form 483 for "Sciegen Pharmaceuticals Inc" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Sciegen Pharmaceuticals Inc?

The most recent FDA inspection on file ended May 15, 2026 at Hauppauge, NY and was classified VAI. FDA has 14 inspections of Sciegen Pharmaceuticals Inc on file, 1 of them classified OAI (official action indicated).

Has Sciegen Pharmaceuticals Inc had an FDA recall?

Yes. Sciegen Pharmaceuticals Inc has 7 FDA recalls on record. The most recent started Feb 17, 2023.

Need more than this page shows? Ask about Sciegen Pharmaceuticals Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.